Skip to main content

View full-text article in PMC

. 2014 May 1;17(5):558–570. doi: 10.1089/jmf.2013.2836

Table 5.

Changes in the Outcome Variables of the Subjects After Intervention

	Bofutsushosan (n=55)	Placebo (n=56)	P value^a
Body weight, kg
Week 8 – baseline	−0.86±1.73	−1.05±1.66	.622
P value^b	.0005^*	.0001^*
WC, cm
Week 8 – baseline	−1.79±2.93	−1.84±2.68	.442
P value^b	.0003^*	.0001^*
BMI, kg/m²
Week 8—baseline	−0.32±0.66	−0.41±0.59	.334
P value^b	.0008^*	.0001^*
Body fat percent
Week 8 – baseline	−0.67±1.6	−0.68±1.26	.742
P value^b	.0096^*	.0014^*
Body fat mass, kg
Week 8 – baseline	−0.97±1.65	−0.89±1.25	.401
P value^b	.0005^*	.0001^*
RMR, kcal/d
Week 8 – baseline	−11.19±451.4	−12.2±495.24	.911
P value^b	.8731	.8755
Fasting BST, mg/dL
Week 8 – baseline	0.14±8.16	0.32±5.5	.783
P value^b	.9102	.7138
T-Chol, mg/dL^c
Week 8 – baseline	−11.45±27.39	−3.85±19.65	.586
P value^b	.0098^*	.2165
HDL, mg/dL^c
Week 8 – baseline	−2.81±8.24	1.07±7.68	.157
P value^b	.0327^*	.3762
TG, mg/dL
Week 8 – baseline	−7.43±59.61	−15.34±59.73	.366
P value^b	.4239	.1079
KOQOL
Week 8 – baseline	−2.69±7.1	−1.31±14.92	.382
P value^b	.0184^*	.5727
SBP, mmHg
Week 8 – baseline	−1.9±11.43	−4.76±11.29	.782
P value^b	.2864	.0102^*
DBP, mmHg
Week 8 – baseline	−1.24±9.73	−3.76±11.87	.265
P value^b	.4145	.0494^*
PR, bpm
Week 8 – baseline	−2.67±8.1	−0.27±9.96	.343
P value^b	.0389^*	.8640

^{^a}

Bofutsushosan vs. placebo (by independent t test).

^{^b}

Pre- vs. post-treatment within group (by paired t test).

^{^c}

The treatment effects on this parameter were adjusted using general linear model.

^{^*}

P<.05.

SBP, systolic blood pressure; DBP, diastolic blood pressure; PR, pulse rate.